Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.735 USD | -2.29% | -13.51% | +170.43% |
Apr. 10 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
Mar. 18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
Financials (USD)
Sales 2024 * | 106M | Sales 2025 * | 220M | Capitalization | 1B |
---|---|---|---|---|---|
Net income 2024 * | -241M | Net income 2025 * | -164M | EV / Sales 2024 * | 7.28 x |
Net cash position 2024 * | 231M | Net cash position 2025 * | 228M | EV / Sales 2025 * | 3.53 x |
P/E ratio 2024 * |
-3.73
x | P/E ratio 2025 * |
-5.7
x | Employees | 296 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.5% |
Latest transcript on Arcutis Biotherapeutics, Inc.
1 day | -2.29% | ||
1 week | -13.51% | ||
Current month | -11.86% | ||
1 month | -9.11% | ||
3 months | +108.47% | ||
6 months | +261.70% | ||
Current year | +170.43% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 55 | 15-12-31 |
Rajvir Madan
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Jay Ramsinghani
COO | Chief Operating Officer | - | 20-05-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Heron
CHM | Chairman | 53 | 16-03-31 |
Founder | 69 | 16-05-31 | |
Keith Leonard
BRD | Director/Board Member | 62 | 21-09-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 8.74 | -2.24% | 1,595,733 |
24-04-22 | 8.94 | -1.76% | 1,227,500 |
24-04-19 | 9.1 | -3.70% | 4,520,740 |
24-04-18 | 9.45 | -7.80% | 2,918,549 |
24-04-17 | 10.25 | +1.49% | 2,515,933 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+170.43% | 1B | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+2.18% | 22.19B | |
-16.16% | 21.33B | |
-7.33% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- ARQT Stock